The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Completely percutaneous transcatheter aortic valve implantation through transaxillary route: an evolving concept
EuroIntervention 2012;7:1340-1342 publish online ahead of print December 2011. DOI: 10.4244/EIJV7I11A210
Nicolas M. van Mieghem1*, MD; Christian Lüthen2, MD; Frans Oei3, MD, PhD; MD; Carl Schultz1, MD, PhD; Jurgen Ligthart1, BSc; Arie-Pieter Kappetein3, MD, PhD; Peter P. de Jaegere1, MD, PhD
1. Department of Interventional Cardiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 2. Department of Anesthesiology, Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands; 3. Department of Cardio-Thoracic Surgery, Thor
Transcatheter aortic valve implantation (TAVI) is a valid treatment option for patients with symptomatic aortic stenosis (AS) and a high operative risk1,2. Transfemoral arterial access is generally considered the access site of first choice and is feasible in a completely percutaneous fashion. In case of unfavourable femoral-iliac arterial vessels, the transapical, transaxillary (or trans-subclavian) and direct aortic access are alternative strategies for TAVI, yet require surgical techniques3. We present the first transaxillary TAVI using an exclusively percutaneous approach and focus on the step-by-step key aspects of this strategy.
A 78-year-old male was accepted for TAVI because of severe symptomatic ...